Brightside rejects revised Markerstudy offer

Countdown

The board of Brightside has rejected Markerstudy’s revised offer as “fundamentally” undervaluing the broker and has dismissed the need for future takeover talks.

Markerstudy had called on Brightside to extend the deadline again for takeover talks as it cut the value of its bid from £123m to at most £100m.

However Brightside hit back saying that the proposed reduced offer of between 20-22p "fundamentally undervalues the company and therefore [it] sees no need in proceeding".

In a statement to the Stock Exchange it added that throughout discussions with Markerstudy it had "concerns about their ability to secure the necessary debt financing to fund an offer

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

FSCS gives first insight on increasing levy to £394m

The Financial Services Compensation Scheme has indicated its levy for 2025/26 will rise to £394m from £265m this financial year as it cited having lower surpluses to carry forward and offset bills – a factor that has benefited brokers for two years in a row.

Konsileo seals £8m fundraise

Top 100 insurance broker Konsileo has completed an £8m fundraise to accelerate its expansion across the UK, Insurance Age can reveal.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: